glycine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients' diagnoses included chronic lymphocytic leukemia, hairy cell leukemia, and follicular lymphoma." | 1.72 | A Method for the Elution of Anti-CD20 With an EDTA/Glycine Acid Solution for Accurate Immunophenotyping of B Lymphocytes Sensitized With Rituximab. ( Fuentes-Chávez, E; Gómez-Almaguer, D; Jaime-Pérez, JC; Maltez, MM; Méndez-Ramírez, N; Salazar-Riojas, R, 2022) |
| " Together, our data suggest the potential for proteasome inhibitor based therapy in CLL and the rationale design of drug combination strategies based on CLL biology." | 1.40 | The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs. ( Advani, P; Akhtar, D; Chanan-Khan, A; Chitta, K; Colon-Otero, G; Foran, J; Khan, AN; Masood, A; Miller, KC; Paulus, A; Rivera, C; Roy, V, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Fuentes-Chávez, E | 1 |
| Méndez-Ramírez, N | 1 |
| Maltez, MM | 1 |
| Salazar-Riojas, R | 1 |
| Gómez-Almaguer, D | 1 |
| Jaime-Pérez, JC | 1 |
| Blombery, P | 1 |
| Thompson, ER | 1 |
| Nguyen, T | 1 |
| Birkinshaw, RW | 1 |
| Gong, JN | 1 |
| Chen, X | 1 |
| McBean, M | 1 |
| Thijssen, R | 1 |
| Conway, T | 1 |
| Anderson, MA | 1 |
| Seymour, JF | 1 |
| Westerman, DA | 1 |
| Czabotar, PE | 1 |
| Huang, DCS | 1 |
| Roberts, AW | 1 |
| Chen, TL | 1 |
| Harrington, B | 1 |
| Truxall, J | 1 |
| Wasmuth, R | 1 |
| Prouty, A | 1 |
| Sloan, S | 1 |
| Lehman, AM | 1 |
| Sampath, D | 1 |
| Orlemans, E | 1 |
| Baiocchi, RA | 1 |
| Alinari, L | 1 |
| Byrd, JC | 1 |
| Woyach, JA | 1 |
| Hertlein, E | 1 |
| Roschewski, M | 2 |
| Farooqui, M | 2 |
| Aue, G | 2 |
| Wilhelm, F | 1 |
| Wiestner, A | 2 |
| Paulus, A | 1 |
| Masood, A | 1 |
| Miller, KC | 1 |
| Khan, AN | 1 |
| Akhtar, D | 1 |
| Advani, P | 1 |
| Foran, J | 1 |
| Rivera, C | 1 |
| Roy, V | 1 |
| Colon-Otero, G | 1 |
| Chitta, K | 1 |
| Chanan-Khan, A | 1 |
| Chapman, CM | 1 |
| Sun, X | 1 |
| Stennett, L | 1 |
| Gibellini, F | 1 |
| Arthur, D | 1 |
| Pérez-Galán, P | 1 |
| Beaumont, A | 1 |
| Brouet, JC | 1 |
| Roques, BP | 1 |
1 trial available for glycine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies.
Topics: Aged; Antineoplastic Agents; Enzyme Inhibitors; Female; Glycine; Humans; Leukemia, Lymphocytic, Chro | 2013 |
6 other studies available for glycine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
A Method for the Elution of Anti-CD20 With an EDTA/Glycine Acid Solution for Accurate Immunophenotyping of B Lymphocytes Sensitized With Rituximab.
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; B-Lymphocytes; Edetic | 2022 |
Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax.
Topics: Amino Acid Substitution; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cohort Stud | 2020 |
Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL.
Topics: Adenine; Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Drug Resistance, Neoplasm; Gl | 2021 |
The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2014 |
ON 01910.Na is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K/AKT inhibition and induction of oxidative stress.
Topics: Activating Transcription Factor 3; Apoptosis; Blotting, Western; Cell Line, Tumor; Female; Gene Expr | 2012 |
Neutral endopeptidase 24.11 and angiotensin converting enzyme like activity in CALLA positive and CALLA negative lymphoid cells.
Topics: Animals; Antigens, Differentiation; Antigens, Neoplasm; Antigens, Surface; B-Lymphocytes; Brain; Cel | 1989 |